Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility
- PMID: 22930247
- DOI: 10.1007/s12020-012-9778-9
Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility
Abstract
Luteal phase deficiency (LPD) is a consequence of the corpus luteum (CL) inability to produce and preserve adequate levels of progesterone. This is clinically manifested by short menstrual cycles and infertility. Abnormal follicular development, defects in neo-angiogenesis or inadequate steroidogenesis in the lutein cells of the CL have been implicated in CL dysfunction and LPD. LPD and polycystic ovary syndrome (PCOS) are independent disorders sharing common pathophysiological profiles. Factors such as hyperinsulinemia, AMH excess, and defects in angiogenesis of CL are at the origin of both LPD and PCOS. In PCOS ovulatory cycles, infertility could result from dysfunctional CL. The aim of this review was to investigate common mechanisms of infertility in CL dysfunction and PCOS.
Similar articles
-
Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.Hum Reprod. 2020 Jul 1;35(7):1655-1665. doi: 10.1093/humrep/deaa098. Hum Reprod. 2020. PMID: 32558920 Free PMC article.
-
Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.Hum Reprod. 2013 Mar;28(3):762-9. doi: 10.1093/humrep/des460. Epub 2013 Jan 14. Hum Reprod. 2013. PMID: 23321213
-
Lipoprotein-cholesterol levels in infertile women with luteal phase deficiency.Fertil Steril. 1991 May;55(5):916-21. Fertil Steril. 1991. PMID: 2022269
-
LH pulses and the corpus luteum: the luteal phase deficiency LPD).Vitam Horm. 2001;63:131-58. doi: 10.1016/s0083-6729(01)63005-x. Vitam Horm. 2001. PMID: 11358113 Review.
-
Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review.Reprod Biol Endocrinol. 2015 Dec 21;13:137. doi: 10.1186/s12958-015-0134-9. Reprod Biol Endocrinol. 2015. PMID: 26691645 Free PMC article. Review.
Cited by
-
Autoantibodies Targeting the Hypothalamic-Pituitary-Ovarian Axis in Polycystic Ovary Syndrome: Emerging Key Players in Pathogenesis?Int J Mol Sci. 2025 Apr 26;26(9):4121. doi: 10.3390/ijms26094121. Int J Mol Sci. 2025. PMID: 40362363 Free PMC article. Review.
-
Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development.J Clin Endocrinol Metab. 2015 Feb;100(2):744-53. doi: 10.1210/jc.2014-2086. Epub 2014 Nov 13. J Clin Endocrinol Metab. 2015. PMID: 25393639 Free PMC article.
-
The Roles of Autophagy in the Genesis and Development of Polycystic Ovary Syndrome.Reprod Sci. 2023 Oct;30(10):2920-2931. doi: 10.1007/s43032-023-01255-3. Epub 2023 May 19. Reprod Sci. 2023. PMID: 37204635 Review.
-
Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.J Mol Endocrinol. 2018 Oct 16;61(4):R161-R184. doi: 10.1530/JME-18-0079. J Mol Endocrinol. 2018. PMID: 29941488 Free PMC article. Review.
-
Comparing programmed, modified natural and natural cycle frozen embryo transfer on obstetric outcomes in polycystic ovary syndrome: a national cohort study.J Assist Reprod Genet. 2025 Jun 18. doi: 10.1007/s10815-025-03523-4. Online ahead of print. J Assist Reprod Genet. 2025. PMID: 40531303
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical